ロード中...

Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC

The fibroblast growth factor receptor FGFR1 is a therapeutic target under investigation in multiple solid tumors and clinical trials of selective tyrosine kinase inhibitors (TKI) are underway. Treatment with single TKI represents a logical step towards personalized cancer therapy, but intrinsic and...

詳細記述

保存先:
書誌詳細
出版年:Cancer Res
主要な著者: Singleton, Katherine R., Hinz, Trista K., Kleczko, Emily K., Marek, Lindsay A., Kwak, Jeff, Harp, Taylor, Kim, Jihye, Tan, Aik Choon, Heasley, Lynn E.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609283/
https://ncbi.nlm.nih.gov/pubmed/26359452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-0509
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!